Double-Blind Randomized Placebo-Controlled Trial of a Proprietary Full Hemp Flower Formulation for Long COVID

Publication date: Mar 19, 2024

Concepts Keywords
Cannabinoids Controlled
Pcr Covid
Rich Day
Sunflower Disorder
Weekly Double
Enrolled
Non
Placebo
Positive
Randomized
Testing
Treatment
Trial
Visit
Xltran

Semantics

Type Source Name
disease MESH Long COVID
drug DRUGBANK Medical Cannabis
disease MESH COVID-19
pathway REACTOME SARS-CoV-2 Infection
disease MESH cognitive impairment
disease IDO acute infection
disease VO effective
drug DRUGBANK Metamfetamine
drug DRUGBANK Cocaine
drug DRUGBANK Phencyclidine
drug DRUGBANK Warfarin
drug DRUGBANK Heparin
drug DRUGBANK Digoxin
drug DRUGBANK Amiodarone
drug DRUGBANK Isoniazid
drug DRUGBANK Phenytoin
drug DRUGBANK Fluconazole
drug DRUGBANK Methotrexate
drug DRUGBANK Probenecid
drug DRUGBANK Raloxifene
disease VO effectiveness
disease VO protocol
disease IDO intervention
drug DRUGBANK Prednisone
disease MESH cardiac disease
disease MESH myocardial infarction
disease MESH hypertension
disease MESH heart failure
disease MESH coronary artery disease
disease MESH psychiatric disorder
disease MESH obsessive-compulsive disorder
disease MESH alcohol use disorder
disease MESH substance use disorder
disease IDO history
disease MESH bipolar disorder
disease MESH schizophrenia
disease MESH schizoaffective disorder
disease MESH suicide
disease MESH allergies
drug DRUGBANK Polysorbate 20

Original Article

(Visited 1 times, 1 visits today)